Page 46 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 16 ฉบับที่ 1

36

°√¡°“√·æ∑¬å·ºπ‰∑¬·≈–°“√·æ∑¬å∑“߇≈◊Õ° ‡≈¢∑’Ë À¬ÿ¥„™â¬“‡ªìπ‡«≈“ 1 ‡¥◊Õπ ¬“Õ¿—¬ “≈’ ·≈–¬“À≈Õ°

01-2558 ¢π“¥ 300 ¡‘≈≈‘°√—¡ ‡μ√’¬¡‚¥¬‚√ß欓∫“≈ÕŸà∑Õß
ºŸâ‡¢â“√à«¡«‘®—¬ ´÷Ë߉¥â√—∫°“√√—∫√Õß¡“μ√∞“π Good manufacturing

ºŸâ‡¢â“√à«¡«‘®—¬∑’ˇ¢â“√à«¡‚§√ß°“√∑—ÈßÀ¡¥ 66 √“¬ practice (GMP) μ‘¥μ“¡º≈°“√√—°…“∑—Èß ‘Èπ 5 §√—Èß
§”π«≥‰¥â®“° Ÿμ√§”π«≥¢π“¥°≈ÿà¡μ—«Õ¬à“ß°“√ §◊Õ «—π∑’Ë 0, 30, 60, 90 ·≈– 120 ‚¥¬∫—π∑÷°
«‘®—¬‡™‘ß∑¥≈Õß∑’Ë¡’°≈ÿà¡μ—«Õ¬à“ß 2 °≈ÿà¡ (°≈ÿà¡ ª√–«—μ‘°“√„™â¬“æàπ∫√√‡∑“Õ“°“√‡Àπ◊ËÕ¬ÀÕ∫,

∑¥≈Õß·≈–°≈ÿࡧ«∫§ÿ¡) √«¡°—∫®”π«πºŸâ‡¢â“√à«¡ §«“¡‡¢â¡¢âπ¢ÕßÕÕ°´‘‡®π„π‡≈◊Õ¥ (O saturation),
2
«‘®—¬∑’˧“¥«à“®–À“¬‰ª∑’ËÕ—μ√“√âÕ¬≈– 10 (R = 0.1) ¡√√∂¿“æªÕ¥ (Lung function), √–¥—∫¿“«–

‚¥¬¡’‡°≥±å§—¥‡¢â“ºŸâ‡¢â“√à«¡«‘®—¬§◊Õ (1) ºŸâªÉ«¬∑’ˉ¥â À“¬„®≈”∫“° (Modified medical research coun-
√—∫°“√«‘π‘®©—¬‚¥¬·æ∑¬å·ºπªí®®ÿ∫—π«à“‡ªìπ‚√§ cil dyspnea score; mMRC), ¡√√∂¿“æ√à“ß°“¬
ªÕ¥Õÿ¥°—Èπ‡√◊ÈÕ√—ß·∫∫§ß∑’Ë √–¬–∑’Ë 1-2 ¡“√—∫°“√ ¥â«¬°“√‡¥‘π 6 π“∑’ (six minute walk test),

μ√«®√—°…“ ≥ ·ºπ°ºŸâªÉ«¬πÕ°§≈‘π‘°‚√§∂ÿß≈¡ ·≈–§ÿ≥¿“æ™’«‘μ COPD Assessment Test (CAT)
ªÕ¥Õÿ¥°—Èπ‡√◊ÈÕ√—ß ‚√ß欓∫“≈‡∑‘ß (2) ºŸâªÉ«¬∑—Èß‡æ» ´÷Ë߇ªìπª√–‡¡‘πº≈°√–∑∫¢Õß‚√§∑’Ë¡’μàÕ°“√∑”
™“¬·≈–À≠‘ß∑’Ë¡’Õ“¬ÿ√–À«à“ß 40-80 ªï (3) ºŸâ‡¢â“√à«¡ °‘®«—μ√ª√–®”«—π·≈–§«“¡º“ ÿ¢¢ÕߺŸâªÉ«¬√à«¡°—∫

«‘®—¬À≠‘ß«—¬‡®√‘≠æ—π∏å∑ÿ°√“¬μâÕß¡’°“√§ÿ¡°”‡π‘¥∑’Ë °“√μ√«®‡≈◊Õ¥∑“ßÀâÕߪؑ∫—μ‘°“√ 2 §√—Èß §◊Õ «—π∑’Ë 0
‡™◊ËÕ∂◊Õ‰¥âÕ¬à“ßπâÕ¬ 2 —ª¥“Àå∑—Èß°àÕπ·≈–À≈—߇¢â“ ·≈– 90 ¥—ß·ºπ¿“æ∑’Ë 1
√à«¡‚§√ß°“√ ·≈– (4) μâÕ߉¡à‡ªìπ‚√§‡∫“À«“π·≈– °“√«‘‡§√“–Àå¢âÕ¡Ÿ≈

¡’πÈ”μ“≈πâÕ¬°«à“À√◊Õ‡∑à“°—∫ 126 mg/dl «‘‡§√“–Àåº≈‚¥¬„™â ∂‘쑇™‘ßæ√√≥π“ ‰¥â·°à §à“
§«“¡∂’Ë §à“√âÕ¬≈– §à“‡©≈’ˬ (Mean) à«π‡∫’ˬ߇∫π
2. «‘∏’°“√»÷°…“
¡“μ√∞“𠇪ìπμâπ ·≈– ∂‘쑇™‘ßÕπÿ¡“π ‰¥â·°à °“√
ß“π«‘®—¬§√—Èßπ’È ‡ªìπ°“√»÷°…“‡™‘ß∑¥≈Õß (ex- «‘‡§√“–Àå¢âÕ¡Ÿ≈¥â«¬ Independent t-test, Chi-
perimental study) ·∫∫ ÿà¡ ª°ªî¥ºŸâ‡¢â“√à«¡ square ·≈– Repeated one-way ANOVA

‚§√ß°“√·≈–ºŸâª√–‡¡‘πº≈≈—æ∏å (double-blind ran- °”Àπ¥§à“§«“¡‡™◊ËÕ¡—Ëπ∑’Ë√âÕ¬≈– 95 ·≈–°√≥’ºŸâ‡¢â“
domized controlled trial) ·∫àß°≈ÿࡺŸâ‡¢â“√à«¡ √à«¡«‘®—¬ÕÕ°®“°°“√»÷°…“°àÕπ§√∫°”Àπ¥®–

«‘®—¬∑’ˇ¢â“√à«¡°“√«‘®—¬ 66 √“¬ÕÕ°‡ªìπ 2 °≈ÿࡥ⫬ «‘‡§√“–Àåº≈‚¥¬„™âÀ≈—° intention to treat
°“√®—∫©≈“° °≈ÿà¡≈– 33 √“¬ °≈ÿà¡·√°‡ªìπ°≈ÿà¡
º≈°“√»÷°…“
∑¥≈Õ߉¥â√—∫¬“Õ¿—¬ “≈’ ·≈–°≈ÿà¡∑’Ë 2 °≈ÿࡧ«∫§ÿ¡

‰¥â√—∫¬“À≈Õ° ‚¥¬ºŸâ‡¢â“√à«¡«‘®—¬∑—Èß 2 °≈ÿࡉ¥â√—∫ ¢âÕ¡Ÿ≈∑—Ë«‰ª
°“√√—°…“‚√§ªÕ¥Õÿ¥°—Èπ‡√◊ÈÕ√—ßμ“¡¡“μ√∞“π°“√ ß“π«‘®—¬§√—Èßπ’È¡’ºŸâ‡¢â“√à«¡«‘®—¬‡¢â“√à«¡‚§√ß°“√∑—Èß
·æ∑¬å·ºπªí®®ÿ∫—π ∑—Èß 2 °≈ÿà¡®–‰¥â√—∫¬“§√—Èß≈– 900 ‘Èπ 66 √“¬ ÿà¡Õ‘ √–‚¥¬°“√®—∫©≈“°·∫à߇ªìπ Õß

¡‘≈≈‘°√—¡ (3 ·§ª´Ÿ≈) °àÕπÕ“À“√ «—π≈– 3 §√—Èß (‡™â“ °≈ÿࡧ◊Õ °≈ÿà¡∑’Ë 1 °≈ÿà¡∑¥≈Õ߉¥â√—∫¬“Õ¿—¬ “≈’®”π«π
°≈“ß«—𠇬Áπ) μ‘¥μàÕ°—π‡ªìπ‡«≈“ 3 ‡¥◊Õπ®“°π—Èπ 33 √“¬ ·≈–°≈ÿà¡∑’Ë 2 °≈ÿࡧ«∫§ÿ¡‰¥â√—∫¬“À≈Õ°